| Dr Taleb Barghouthi, MD | |
|
300 Longwood Venue, Boston Children's Hospital, Boston, MA 02115 | |
| (617) 480-6212 | |
| Not Available |
| Full Name | Dr Taleb Barghouthi |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 300 Longwood Venue, Boston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447675152 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 257611 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Taleb Barghouthi, MD 300 Longwood Venue, Boston Children's Hospital, Boston, MA 02115 Ph: () - | Dr Taleb Barghouthi, MD 300 Longwood Venue, Boston Children's Hospital, Boston, MA 02115 Ph: (617) 480-6212 |
News Archive
Pairing technological innovation with business collaboration to improve conditions for the global poor is the driving force behind the new Hunter and Stephanie Hunt Institute for Engineering and Humanity at SMU's Bobby Lyle School of Engineering.
Machines can be trained to classify images and thus identify tumors in CT scans, mineral compositions in rocks, or pathologies in optical microscopy analyses. This artificial intelligence technique is known as machine learning and has gained new applications in recent years.
MicroStrategy® Incorporated, a leading worldwide provider of business intelligence software, today announced that the new information dashboard recently launched by the Centers for Medicare & Medicaid Services is powered by MicroStrategy.
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
PharmAthene, Inc. today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits.
› Verified 6 days ago
Dr. Steven D. Rauch, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Elliott D. Kozin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-6545 | |
Katherine Nicole Vandenberg, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118 Phone: 617-638-8124 | |
Yoon Sun Chun, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Brigham And Women's Hospital Dept Of Plastic Surgery, Boston, MA 02115 Phone: 617-732-8181 Fax: 617-983-4534 | |
Jaimie Derosa, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 91 Newbury St, Suite 300, Boston, MA 02116 Phone: 617-262-8000 Fax: 617-262-8002 | |
Dr. Usama M Aboelkheir, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Smc8, Boston, MA 02135 Phone: 617-789-5004 Fax: 617-779-6481 | |
Phillip C Song, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3557 |